Skip to main content
  • SELUTION DeNovo Trial: Early Look Shows Procedural Outcomes Improve with Center Experience

    An early look at the SELUTION DeNovo trial shows that procedural results with a novel drug-eluting balloon (DEB) improve with operator experience and that the trial is truly serving “all comers” patients with de novo coronary lesions.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details